Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.